Answers are grounded in this paper and cite their sources.
Partial (9 patients) or complete (11 patients) remission occurred in 20 of 35 patients (57%) with epidermoid carcinoma of the head and neck treated with high-dose intravenous methotrexate. Weekly doses of 60 mg/sq m injected intravenously were used for periods up to 8 to 12 weeks to induce remission. Remission duration ranged from 23 to 604 days, with a mean of 128 days. The same dose administered at 3- to 4-week intervals served to maintain remission. Moderate toxicity occurred except in patients treated twice weekly at a dose of 40 mg/sq m (5 patients) when intoxication was severe.
No takes yet. Share an insight, caveat, or question.
Leone et al. (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: